What caused the 35.27% move in 4888.T stock on 18 Mar 2026?

The rise came with heavy volume (5,861,100.00 shares) and market interest in Stella Pharma’s BNCT pipeline. Traders reacted to perceived clinical or corporate updates; no formal regulatory release was required to spark speculative buying.

What is Meyka AI’s forecast for 4888.T stock versus the current price?

Meyka AI's forecast model projects a yearly price of JPY 302.74 versus the current JPY 560.00, implying an estimated downside of -45.94%. Forecasts are model-based projections and not guarantees.

Are Stella Pharma’s fundamentals supportive of the recent rally in 4888.T stock?

Fundamentals show negative EPS (-5.04), P/S 16.86 and P/B 6.06, which do not support an enduring valuation premium. The rally appears catalyst-driven and speculative rather than fundamentally validated.

What timeline should investors watch for 4888.T stock?

Watch the earnings announcement on 2026-05-12 and any BNCT clinical readouts or regulatory updates. These events typically drive price and liquidity in Stella Pharma on JPX.

JP Stocks

4888.T stock up 35.27% on JPX 18 Mar 2026: heavy volume may reflect BNCT news

ByDanny Kontos March 18, 2026March 18, 2026

The 4888.T stock closed at JPY 560.00 on JPX on 18 Mar 2026, a 35.27% one-day gain on 5,861,100.00 shares traded. This jump followed a wide intraday range from JPY 455.00 to JPY 560.00 and pushed price well above the 50-day average of JPY 341.78. Investors are pricing in progress for Stella Pharma Corporation’s BNCT pipeline, while trading volume was roughly 3.11x the average daily volume, signaling aggressive speculative flows into the biotechnology name in Japan.